The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model.

OBJECTIVE To develop a birth weight (BW), gestational age (GA), and postnatal-weight gain retinopathy of prematurity (ROP) prediction model in a cohort of infants meeting current screening guidelines. METHODS Multivariate logistic regression was applied retrospectively to data from infants born with BW less than 1501 g or GA of 30 weeks or less at a single Philadelphia hospital between January 1, 2004, and December 31, 2009. In the model, BW, GA, and daily weight gain rate were used repeatedly each week to predict risk of Early Treatment of Retinopathy of Prematurity type 1 or 2 ROP. If risk was above a cut-point level, examinations would be indicated. RESULTS Of 524 infants, 20 (4%) had type 1 ROP and received laser treatment; 28 (5%) had type 2 ROP. The model (Children's Hospital of Philadelphia [CHOP]) accurately predicted all infants with type 1 ROP; missed 1 infant with type 2 ROP, who did not require laser treatment; and would have reduced the number of infants requiring examinations by 49%. Raising the cut point to miss one type 1 ROP case would have reduced the need for examinations by 79%. Using daily weight measurements to calculate weight gain rate resulted in slightly higher examination reduction than weekly measurements. CONCLUSIONS The BW-GA-weight gain CHOP ROP model demonstrated accurate ROP risk assessment and a large reduction in the number of ROP examinations compared with current screening guidelines. As a simple logistic equation, it can be calculated by hand or represented as a nomogram for easy clinical use. However, larger studies are needed to achieve a highly precise estimate of sensitivity prior to clinical application.

[1]  A. Hellström,et al.  Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants. , 2012, Archives of ophthalmology.

[2]  A. Samueloff,et al.  Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study. , 2012, American journal of obstetrics and gynecology.

[3]  A. Jefferies,et al.  Neonatal Outcomes of Small for Gestational Age Preterm Infants in Canada , 2011, American Journal of Perinatology.

[4]  Lois E. H. Smith,et al.  Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP. , 2010, Archives of ophthalmology.

[5]  Lois E. H. Smith,et al.  Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. , 2010, Archives of ophthalmology.

[6]  P. Royston,et al.  Prognosis and prognostic research: application and impact of prognostic models in clinical practice , 2009, BMJ : British Medical Journal.

[7]  Lois E. H. Smith,et al.  Early Weight Gain Predicts Retinopathy in Preterm Infants: New, Simple, Efficient Approach to Screening , 2009, Pediatrics.

[8]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: what, why, and how? , 2009, BMJ : British Medical Journal.

[9]  J. Martin,et al.  Births : final data for 2006 , 2009 .

[10]  C. Gilbert Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. , 2008, Early human development.

[11]  Lois E. H. Smith,et al.  Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. , 2006, Archives of ophthalmology.

[12]  Section on Ophthalmology Screening Examination of Premature Infants for Retinopathy of Prematurity , 2006, Pediatrics.

[13]  Stephan Dreiseitl,et al.  Nomographic representation of logistic regression models: A case study using patient self-assessment data , 2005, J. Biomed. Informatics.

[14]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[15]  G. Quinn,et al.  Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs , 2005, Pediatrics.

[16]  J. Flynn,et al.  Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. , 2004, Ophthalmology.

[17]  W. Tasman,et al.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. , 2004, Archives of ophthalmology.

[18]  A. Fielder,et al.  Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. , 2003, Archives of ophthalmology.

[19]  Lois E. H. Smith,et al.  Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. , 2003, Pediatrics.

[20]  C. Gilbert,et al.  Blindness in children: control priorities and research opportunities , 2001, The British journal of ophthalmology.

[21]  Lois E. H. Smith,et al.  Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Normand,et al.  Evidence for changing guidelines for routine screening for retinopathy of prematurity. , 2001, Archives of pediatrics & adolescent medicine.

[23]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[24]  C R Bauer,et al.  Longitudinal Growth of Hospitalized Very Low Birth Weight Infants , 1999, Pediatrics.

[25]  D. Clemmons,et al.  Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants. , 1997, The Journal of clinical endocrinology and metabolism.

[26]  A. Fielder The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 1995, Archives of ophthalmology.

[27]  Karen W. Miller,et al.  Incidence and Early Course of Retlnonathy of Prematurity , 1991 .

[28]  P. Fells Section of ophthalmology , 1978 .

[29]  A. Fielder,et al.  Retinopathy of prematurity in the UK I: The organisation of services for screening and treatment , 2002, Eye.

[30]  A. Fielder,et al.  A screening and treatment of retinopathy of prematurity: A collaborative study by the Royal College of Paediatrics and Child Health, the Royal College of Ophthalmologists, the British Association of Perinatal Medicine and the Royal College of Surgeons , 1998 .

[31]  A. Fielder The natural ocular outcome of premature birth and retinopathy: status at 1 year. , 1995, Archives of ophthalmology.

[32]  J. Flynn,et al.  THE CRYOTHERAPY FOR RETINOPATHY OF PREMATURITY GROUP: INCIDENCE AND EARLY COURSE OF RETINOPATHY OF PREMATURITY , 1991 .